Alembic Ltd — Investor Relations & Filings
Alembic Ltd is a long-standing pharmaceutical enterprise focused on the development, manufacturing, and marketing of generic pharmaceutical products and active pharmaceutical ingredients (APIs). Established in 1907, the company operates through a vertically integrated model, covering the entire value chain from research and development to commercial distribution. Its product portfolio spans several therapeutic areas, including anti-infectives, cardiovascular, gastrointestinal, and respiratory treatments. The organization maintains advanced manufacturing facilities and dedicated research centers to support its global supply chain. Alembic serves diverse international markets, providing high-quality formulations and bulk drugs to healthcare providers and partners. The company is recognized for its expertise in fermentation technology and its commitment to meeting international regulatory standards for pharmaceutical production.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Copy of Newspaper Publication | 2026-04-17 | English | |
| Copy of Newspaper Publication | 2026-04-15 | English | |
| Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-06 | English | |
| Trading Window | 2026-03-27 | English | |
| Copy of Newspaper Publication | 2026-02-13 | English | |
| Outcome of Board Meeting | 2026-02-12 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
9 filings
| |||||
| 42205520 | Copy of Newspaper Publication | 2026-04-17 | English | ||
| 42172805 | Copy of Newspaper Publication | 2026-04-15 | English | ||
| 42204512 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-06 | English | ||
| 42219965 | Trading Window | 2026-03-27 | English | ||
| 42245314 | Copy of Newspaper Publication | 2026-02-13 | English | ||
| 42178329 | Outcome of Board Meeting | 2026-02-12 | English | ||
| 42210245 | Copy of Newspaper Publication | 2026-02-11 | English | ||
| 42231514 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-01-05 | English | ||
| 42204406 | Updates | 2026-01-01 | English | ||
|
2025
6 filings
| |||||
| 42250544 | Trading Window | 2025-12-26 | English | ||
| 42231020 | Copy of Newspaper Publication | 2025-12-15 | English | ||
| 42248750 | Copy of Newspaper Publication | 2025-11-28 | English | ||
| 42255022 | Copy of Newspaper Publication | 2025-10-15 | English | ||
| 42281345 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2025-10-06 | English | ||
| 42256889 | Updates | 2025-10-01 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ASKA Pharmaceutical Holdings CO., Ltd.
Specializes in hormone-related pharmaceuticals for internal…
|
4886 | JP | Manufacturing |
|
ASPEN PHARMACARE HOLDINGS LIMITED
Global specialty and branded pharmaceutical company deliver…
|
APN | ZA | Manufacturing |
|
Aspire Biopharma Holdings, Inc.
Develops sublingual drug delivery technologies for needle-f…
|
ASBP | US | Manufacturing |
|
ASSEMBLY BIOSCIENCES, INC.
A clinical-stage biotech developing small molecule antivira…
|
ASMB | US | Manufacturing |
|
Assertio Holdings, Inc.
Pharmaceutical company managing branded products for neurol…
|
ASRT | US | Manufacturing |
|
ASSTON PHARMACEUTICALS LIMITED
Develops, manufactures, and distributes generic medications…
|
544445 | IN | Manufacturing |
|
ASSURE TECH (HANGZHOU) CO., LTD.
Develops and manufactures IVD reagents and POCT solutions f…
|
688075 | CN | Manufacturing |
|
ASTAL LABORATORIES LIMITED
Develops, manufactures, and markets a diverse range of phar…
|
512600 | IN | Manufacturing |
|
Astellas Pharma Inc.
A global pharmaceutical company turning innovative science …
|
4503 | JP | Manufacturing |
|
ASTONEA LABS LIMITED
A CDMO specializing in pharmaceutical and cosmeceutical R&D…
|
544409 | IN | Manufacturing |
Alembic Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/61312/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=61312 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=61312 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=61312 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 61312}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Alembic Ltd (id: 61312)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.